SMS Pharmaceuticals Limited (SMSPHARMA.BO)

INR 242.45

(2.08%)

Total Liabilities Summary of SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited's latest annual total liabilities in 2023 was 4.97 Billion INR , up 18.77% from previous year.
SMS Pharmaceuticals Limited's latest quarterly total liabilities in 2023 FY was 4.97 Billion INR , up 18.77% from previous quarter.
SMS Pharmaceuticals Limited reported annual total liabilities of 4.19 Billion INR in 2022, up 7.67% from previous year.
SMS Pharmaceuticals Limited reported annual total liabilities of 3.89 Billion INR in 2021, down -3.1% from previous year.
SMS Pharmaceuticals Limited reported quarterly total liabilities of - INR for 2023 Q3, down -100.0% from previous quarter.
SMS Pharmaceuticals Limited reported quarterly total liabilities of 4.98 Billion INR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of SMS Pharmaceuticals Limited (2023 - 2004)

Historical Annual Total Liabilities of SMS Pharmaceuticals Limited (2023 - 2004)

Year	Total Liabilities	Total Liabilities Growth
2023	4.97 Billion INR	18.77%
2022	4.19 Billion INR	7.67%
2021	3.89 Billion INR	-3.1%
2020	4.01 Billion INR	54.69%
2019	2.59 Billion INR	9.62%
2018	2.36 Billion INR	8.65%
2017	2.18 Billion INR	-8.54%
2016	2.38 Billion INR	-0.47%
2015	2.39 Billion INR	-16.38%
2014	2.86 Billion INR	-0.35%
2013	2.87 Billion INR	26.49%
2012	2.27 Billion INR	-16.05%
2011	2.7 Billion INR	7.79%
2010	2.51 Billion INR	13.2%
2009	2.21 Billion INR	19.15%
2008	1.86 Billion INR	31.12%
2007	1.42 Billion INR	24.19%
2006	1.14 Billion INR	3.57%
2005	1.1 Billion INR	4.47%
2004	1.05 Billion INR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 Q1	- INR	-100.0%
2023 Q3	- INR	-100.0%
2023 Q2	4.98 Billion INR	0.0%
2023 FY	4.97 Billion INR	18.77%
2023 Q4	4.97 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q4	4.19 Billion INR	0.0%
2022 FY	4.19 Billion INR	7.67%
2022 Q1	- INR	-100.0%
2022 Q2	4.04 Billion INR	0.0%
2021 Q4	3.89 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2021 Q2	4.25 Billion INR	0.0%
2021 FY	3.89 Billion INR	-3.1%
2020 Q2	3.23 Billion INR	0.0%
2020 FY	4.01 Billion INR	54.69%
2020 Q4	4.01 Billion INR	0.0%
2019 FY	2.59 Billion INR	9.62%
2019 Q2	2.32 Billion INR	0.0%
2019 Q4	2.59 Billion INR	0.0%
2018 FY	2.36 Billion INR	8.65%
2018 Q4	2.36 Billion INR	0.0%
2017 FY	2.18 Billion INR	-8.54%
2016 Q2	3.97 Billion INR	0.0%
2016 FY	2.38 Billion INR	-0.47%
2015 Q4	2.39 Billion INR	0.0%
2015 FY	2.39 Billion INR	-16.38%
2015 Q2	3.19 Billion INR	0.0%
2014 Q4	2.86 Billion INR	0.0%
2014 Q2	2.72 Billion INR	0.0%
2014 FY	2.86 Billion INR	-0.35%
2013 Q4	2.87 Billion INR	0.0%
2013 FY	2.87 Billion INR	26.49%
2013 Q2	2.48 Billion INR	0.0%
2012 FY	2.27 Billion INR	-16.05%
2012 Q4	2.27 Billion INR	0.0%
2011 FY	2.7 Billion INR	7.79%
2011 Q4	2.7 Billion INR	0.0%
2010 FY	2.51 Billion INR	13.2%
2009 FY	2.21 Billion INR	19.15%
2008 FY	1.86 Billion INR	31.12%
2007 FY	1.42 Billion INR	24.19%
2006 FY	1.14 Billion INR	3.57%
2005 FY	1.1 Billion INR	4.47%
2004 FY	1.05 Billion INR	0.0%

Peer Total Liabilities Comparison of SMS Pharmaceuticals Limited

Name	Total Liabilities	Total Liabilities Difference
Abbott India Limited	14.94 Billion INR	66.696%
Cipla Limited	59.15 Billion INR	91.585%
Gland Pharma Limited	19.37 Billion INR	74.308%
GlaxoSmithKline Pharmaceuticals Limited	17.96 Billion INR	72.287%
Kopran Limited	2.52 Billion INR	-97.524%
Marksans Pharma Limited	5.95 Billion INR	16.349%
NGL Fine-Chem Limited	929.03 Million INR	-435.783%
Pfizer Limited	6.33 Billion INR	21.394%
Sanofi India Limited	6.99 Billion INR	28.85%